Ewa Bieniek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ewa Bieniek has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Katarzyna Wojciechowska-Durczynska
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, 93-338 Lodz, Poland
1 shared publication - Kinga Krawczyk-Rusiecka
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
1 shared publication - Krzysztof Cezary Lewandowski
Faculty of Medicine—Collegium Medicum, Department of Internal Medicine, Endocrinology & Diabetes, Mazovian University in Plock, Dąbrowskiego 2, 09-402 Plock, Poland
1 shared publication - Marta Mikulak
Faculty of Medicine—Collegium Medicum, Department of Internal Medicine, Endocrinology & Diabetes, Mazovian University in Plock, Dąbrowskiego 2, 09-402 Plock, Poland
1 shared publication - Wojciech Horzelski
Faculty of Mathematics and Computer Science, University of Lodz, Lodz, Poland
1 shared publication
Latest Publications
- Open Access
- 7 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4410
Effect of a Prior Two-Hour Postural Test on Seated Saline Suppression Test Results in Patients Predominantly Evaluated for Adrenal Incidentalomas
Background/Objectives: The Seated Saline Suppression Test (SSST) is widely used for investigation of primary hyperaldosteronism (PA); however, the impact of a one-hour sitting period prior to SSST (as recommended by the Endocrine Society, with a 7.8 ng/dL aldosterone cut-off) on the test outcome remains unclear. Methods: In 82 individuals (23 males) aged 57.3 ± 12.6 years, BMI 27.1 ± 5.1 kg/m2, where the majority were diagnosed with adrenal incidentalomas (n = 75), we performed an SSST preceded by a 120 min postural test (first protocol), or immediately after waking (second protocol, a cross-over design). Results: Though aldosterone and renin concentrations before the onset of SSST were higher after the first protocol (p < 0.001), an overall suppression of aldosterone was not different after the first versus the second protocol (6.34 ± 0.68 ng/dL (mean ± SEM) versus 5.74 ± 0.66 ng/dL, p = 0.124). There was no significant difference between the number of individuals with aldosterone > 10 ng/dL, i.e., nine (11%) for the first protocol versus eight (9.75%) for the second protocol, p = 1.00, and for the “grey zone” aldosterone of 7.8–10 ng/mL after SSST (five (6.1%) in each group, p = 1.0). Aldosterone-to-direct-renin ratio (ADR ratio) was higher in those who failed to suppress aldosterone (p < 0.001) but offered a poor prediction of SSST outcome with the lowest ADR ratio of 0.398 ng/dL/µIU/mL in those with aldosterone > 7.8 ng/dL, and the highest ADR ratio of 26.04 ng/dL/µIU/mL for those with aldosterone < 7.8 ng/dL on SSST. Conclusions: Two-hour postural test before SSST does not significantly impact aldosterone suppression after saline infusion, while the ADR ratio does not fully discriminate between those who suppress and those who do not suppress aldosterone secretion on SSST, at least in those with adrenal incidentalomas.
- 7 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4410
Open AccessEffect of a Prior Two-Hour Postural Test on Seated Saline Suppression Test Results in Patients Predominantly Evaluated for Adrenal Incidentalomas
Background/Objectives: The Seated Saline Suppression Test (SSST) is widely used for investigation of primary hyperaldosteronism (PA); however, the impact of a one-hour sitting period prior to SSST (as recommended by the Endocrine Society, with a 7.8 ng/dL aldosterone cut-off) on the test outcome remains unclear. Methods: In 82 individuals (23 males) aged 57.3 ± 12.6 years, BMI 27.1 ± 5.1 kg/m2, where the majority were diagnosed with adrenal incidentalomas (n = 75), we performed an SSST preceded by a 120 min postural test (first protocol), or immediately after waking (second protocol, a cross-over design). Results: Though aldosterone and renin concentrations before the onset of SSST were higher after the first protocol (p < 0.001), an overall suppression of aldosterone was not different after the first versus the second protocol (6.34 ± 0.68 ng/dL (mean ± SEM) versus 5.74 ± 0.66 ng/dL, p = 0.124). There was no significant difference between the number of individuals with aldosterone > 10 ng/dL, i.e., nine (11%) for the first protocol versus eight (9.75%) for the second protocol, p = 1.00, and for the “grey zone” aldosterone of 7.8–10 ng/mL after SSST (five (6.1%) in each group, p = 1.0). Aldosterone-to-direct-renin ratio (ADR ratio) was higher in those who failed to suppress aldosterone (p < 0.001) but offered a poor prediction of SSST outcome with the lowest ADR ratio of 0.398 ng/dL/µIU/mL in those with aldosterone > 7.8 ng/dL, and the highest ADR ratio of 26.04 ng/dL/µIU/mL for those with aldosterone < 7.8 ng/dL on SSST. Conclusions: Two-hour postural test before SSST does not significantly impact aldosterone suppression after saline infusion, while the ADR ratio does not fully discriminate between those who suppress and those who do not suppress aldosterone secretion on SSST, at least in those with adrenal incidentalomas.